IMARC Group, a leading market research company, has recently released a report titled "Bilirubin Meters Market Report by Product (Bench-top, Transcutaneous), Age Group (Neonates, Adults), Indication (Jaundice, Hepatitis), End User (Hospitals and Nursing Home, Clinics, and Others), and Region 2025-2033." The study provides a detailed analysis of the industry, including the global bilirubin meters market size, share, trends, growth and forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

Bilirubin Meters Market Overview

The global bilirubin meters market size reached USD 327.0 Million in 2024 and is projected to reach USD 588.6 Million by 2033. The market is expected to grow at a CAGR of 6.41% during the forecast period from 2025 to 2033. Growth is driven by the rising cases of neonatal jaundice, technological advancements in bilirubin monitoring, and increasing adoption of point-of-care testing for accurate and rapid bilirubin measurements in various clinical settings.

Study Assumption Years

  • Base Year: 2024
  • Historical Years: 2019-2024
  • Forecast Years: 2025-2033

Bilirubin Meters Market Key Takeaways

  • Current Market Size: USD 327.0 Million in 2024
  • CAGR: 6.41% (2025-2033)
  • Forecast Period: 2025-2033
  • The market is driven by the increasing prevalence of neonatal jaundice necessitating efficient bilirubin monitoring tools.
  • Advances in bilirubin monitoring technology enhance accuracy, portability, and ease of use.
  • There is a growing emphasis on point-of-care testing to provide rapid results and improve patient outcomes.
  • The transcutaneous bilirubin meters segment dominates due to its non-invasive nature and bedside usability.
  • Asia Pacific constitutes the largest regional market, propelled by population and healthcare investments.

Request Your Free “Bilirubin Meters Market” Insights Sample PDF: https://www.imarcgroup.com/bilirubin-meters-market/requestsample

Market Growth Factors

  • Increasing Prevalence of Neonatal Jaundice

Neonatal jaundice rises, which will drive growth in the bilirubin meters market during the forthcoming years. Newborns have neonatal jaundice when bilirubin levels rise. This equipment is in demand due to the need for reliable and rapid means to make accurate measurements, enabling early detection and treatment, and preventing the consequences of elevated bilirubin levels. In addition, raising awareness among parents and healthcare professionals about monitoring neonatal jaundice is expected to support the market growth of these meters.

  • Rapid Advancements in Bilirubin Monitoring Technology

Technical progress on bilirubin meters in terms of portability and user-friendliness is a major influence in this market. These include TCB, and non-intrusive spectrophotometry to provide reliable results. Wireless transmission and data processing capabilities allow for better on-location usage and real-time data organization and analysis. Further research and development to create more advanced and innovative devices is well underway and leads to continued expansion of this market.

  • Growing Emphasis on Point-of-Care Testing

More point-of-care testing should increase market growth. Point-of-care bilirubin meters provide rapid results Patient care improves and healthcare processes become more efficient by taking bilirubin measurements near the bedside. This is also likely to reduce the turnaround time from diagnosis within the wards, emergency departments, outpatient departments, nursery, and intensive care unit, which is critical for neonatal care. The increased feasibility and convenience for point-of-care testing is likely to increase the adoption rate of decentralized testing, thus driving the market.

Market Segmentation

Breakup by Product:

  • Bench-top
  • Transcutaneous

Bench-top bilirubin meters offer laboratory-grade, stable platforms for accurate bilirubin assessment in clinical laboratories and hospitals, emphasizing precision and reliability.

Breakup by Age Group:

  • Neonates
  • Adults

Specially designed for newborns, these meters focus on accurate bilirubin monitoring at lower concentration ranges using non-invasive methods in NICUs, maternity wards, and pediatric clinics.

Breakup by Indication:

  • Jaundice
  • Hepatitis

Dominating the indication segment, these meters provide precise bilirubin measurements critical for diagnosing and managing jaundice in neonates and adults associated with liver and hemolytic conditions.

Breakup by End User:

  • Hospitals and Nursing Home
  • Clinics
  • Others

This leading segment includes extensive medical facilities utilizing bilirubin meters in neonatal units, pediatric wards, and adult care for accurate diagnosis and treatment.

Breakup By Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Asia Pacific leads the bilirubin meters market, accounting for the largest market share. This is attributed to the region's large population, increased healthcare investments, and a growing focus on maternal and child health in countries like China and India. The adoption of point-of-care testing also supports demand growth. North America follows with significant market presence, supported by advanced healthcare infrastructure and technology adoption. Europe, Latin America, and the Middle East & Africa show steady growth driven by healthcare developments and disease prevalence.

Access the Latest 2026 Data & Forecasts: https://www.imarcgroup.com/checkout?id=19323&method=1670

Key Players

  • APEL Co. Ltd.
  • Drägerwerk AG & Co. KGaA
  • Mennen Medical Ltd.
  • Micro Lab Instruments
  • Ningbo David Medical Device Co. Ltd.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group,

134 N 4th St. Brooklyn, NY 11249, USA,

Email: sales@imarcgroup.com,

Tel No: (D) +91 120 433 0800,

United States: +1-201971-6302